Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Inventory Average: 2021-2025

Historic Inventory Average for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $44.8 million.

  • Kiniksa Pharmaceuticals International's Inventory Average rose 40.98% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 40.98%. This contributed to the annual value of $28.7 million for FY2024, which is 9.04% up from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Inventory Average of $44.8 million as of Q3 2025, which was up 27.51% from $35.1 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Inventory Average high stood at $44.8 million for Q3 2025, and its period low was $4.3 million during Q2 2021.
  • Moreover, its 3-year median value for Inventory Average was $28.4 million (2023), whereas its average is $29.4 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Inventory Average surged by 290.26% in 2022 and then decreased by 17.07% in 2025.
  • Kiniksa Pharmaceuticals International's Inventory Average (Quarterly) stood at $4.6 million in 2021, then spiked by 290.26% to $18.1 million in 2022, then soared by 56.56% to $28.4 million in 2023, then fell by 2.93% to $27.5 million in 2024, then soared by 40.98% to $44.8 million in 2025.
  • Its last three reported values are $44.8 million in Q3 2025, $35.1 million for Q2 2025, and $24.2 million during Q1 2025.